GABA: A Neurotransmitter Regulating Neural Circuits (P9058)

Target Name: Gamma-aminobutyric-acid A receptor, Rho

NCBI ID: P9058

Gamma-aminobutyric-acid A receptor, Rho

Other Name(s): GABA(C) receptor

GABA: A Neurotransmitter Regulating Neural Circuits

Gamma-aminobutyric-acid (GABA) is a neurotransmitter that plays a crucial role in the regulation of neural circuits in the brain. The GABA receptor, also known as the Rho GABA(C) receptor, is a GABA receptor that is located in various tissues throughout the body, including the brain, nervous system, and organs.

The GABA receptor is a G protein-coupled receptor, which means it is composed of a transmembrane protein that is connected to a intracellular signaling pathway. The GABA receptor has been the focus of intense research in recent years due to its potential as a drug target or biomarker.

GABA is a neurotransmitter that acts on multiple targets throughout the body, including ion channels, neurotransmitter receptors, and enzymes. Its most well-known function is its role in modulating neural activity, particularly in the inhibition of synaptic transmission. GABA has been shown to have a therapeutic effect on a wide range of conditions, including epilepsy, anxiety, and pain.

The GABA receptor is also involved in the regulation of various physiological processes that are critical for life, such as sleep, appetite, and body temperature. GABA has been shown to play a key role in the regulation of sleep-wake cycles and has been linked to the development of insomnia. Additionally, GABA has been shown to regulate food intake and metabolism, which is critical for maintaining energy homeostasis.

GABA has also been shown to have a potential as a drug target in various diseases. For example, GABA has been shown to be downregulated in individuals with major depressive disorder (MDD), and has been shown to have a therapeutic effect on depression-related symptoms. Additionally, GABA has been shown to be involved in the regulation of pain, and has been used as a treatment for chronic pain conditions.

Furthermore, GABA has also been shown to be involved in the regulation of various neurotransmitter systems, including those that are involved in mood regulation, anxiety, and pain. GABA has been shown to interact with dopamine, serotonin, and other neurotransmitters, and has been shown to modulate their activity.

In addition to its potential therapeutic uses, GABA is also a potential biomarker for various diseases. For example, GABA has been shown to be lower in individuals with Alzheimer's disease, and has been used as a potential diagnostic marker for this disease. Additionally, GABA has been shown to be lower in individuals with Parkinson's disease, and has been used as a potential diagnostic marker for this disease.

GABA has also been shown to be involved in the regulation of various physiological processes that are critical for life, such as sleep, appetite, and body temperature. GABA has been shown to play a key role in the regulation of sleep-wake cycles and has been linked to the development of insomnia. Additionally, GABA has been shown to regulate food intake and metabolism, which is critical for maintaining energy homeostasis.

GABA has also been shown to have a potential as a drug target in various diseases. For example, GABA has been shown to be downregulated in individuals with major depressive disorder (MDD), and has been shown to have a therapeutic effect on depression-related symptoms. Additionally, GABA has been shown to be involved in the regulation of pain, and has been used as a treatment for chronic pain conditions.

In conclusion, Gamma-aminobutyric-acid (GABA) is a neurotransmitter that plays a crucial role in the regulation of neural circuits in the brain. The GABA receptor, also known as the Rho GABA(C) receptor, is a GABA receptor that is located in various tissues throughout the body. GABA has been shown to have a

Protein Name: Gamma-aminobutyric-acid A Receptor, Rho

The "Gamma-aminobutyric-acid A receptor, Rho Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Gamma-aminobutyric-acid A receptor, Rho comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets